New screening guidelines for Diabetes and liver cancer Dr. Kamal Kant Kohli5 Feb 2024 10:00 AM ISTFor centuries, doctors have used their hands as essential diagnostic tools-exploring joints and palpating abdomens to assess a patient's health. Often...
Voice-based AI app improves insulin dosage and diabetes management: JAMA Jacinthlyn Sylvia5 Feb 2024 9:45 AM ISTA recent voice-based conversational artificial intelligence (AI) application has demonstrated significant success in optimizing insulin therapy for...
Relieving urinary tract obstructions ups gouty arthritis risk in patients with hyperuricemia Medha Baranwal4 Feb 2024 9:00 PM ISTChina: A recent study published in Medicine journal has revealed an increased risk of gouty arthritis in patients with hyperuricemia and acute...
Novel PET/CT technique accurately diagnoses sub-types of primary aldosteronism: Study Dr. Kamal Kant Kohli4 Feb 2024 8:45 PM ISTChina: A recent study published in The Journal of Nuclear Medicine has shed light on the clinical value of a novel imaging approach, 68Ga-pentixafor...
Novel heparanase inhibitor could prevent diabetic eye and kidney disease in people with diabetes Dr. Kamal Kant Kohli3 Feb 2024 10:30 AM ISTResearchers have found in a new study that Novel agent heparanase inhibitor OVZ/HS-1638 may effectively prevent microvascular permeability changes...
Diabetes medication class tied to lower risk of kidney stones Anshika Mishra3 Feb 2024 9:30 AM ISTRates of kidney stones are on the rise in the United States and around the world. Type 2 diabetes is associated with increased risk of kidney stones,...
Use of tobacco, cannabis and psychoactive substances increases risk of readmission due to DKA in type 1 diabetes Dr. Shravani Dali2 Feb 2024 7:15 PM ISTUse of tobacco, cannabis and psychoactive substances increases the risk of readmission due to Diabetic ketoacidosis in type 1 diabetes suggests a new...
Once-weekly insulin icodec better than once-daily basal insulin analogues in type 2 diabetes: Study Medha Baranwal2 Feb 2024 10:15 AM ISTKarnataka: A meta-analysis of ONWARDS phase 3 randomized controlled trials (RCTs) revealed that once-weekly insulin icodec led to a higher glycated...
Dapagliflozin therapy helps reduce CV mortality in heart failure with improved ejection fraction: JAMA Medha Baranwal1 Feb 2024 11:00 AM ISTUSA: Adding a sodium-glucose transport protein 2 inhibitor therapy to other guideline-directed medical therapies may help lower cardiovascular...
Low-Dose Sulphonylurea and DPP4 Inhibitor Combo lowers blood sugar by augmentating beta cell function Dr Riya Dave1 Feb 2024 10:45 AM ISTIn the pursuit of refining diabetes treatment, a recent unblinded randomized crossover study explored the potential synergy between low-dose...
Evergreen Talk Series: Use of SGLT2i and DPP4i combination in T2DM patients with a history of Genitourinary Tract Infections MD Brand Connect1 Feb 2024 10:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani,...
Empagliflozin and semaglutide combination improves glycemic control and BP but not arterial stiffness Jacinthlyn Sylvia1 Feb 2024 10:15 AM ISTA recent 32-week study investigated the effects of empagliflozin, semaglutide, and their combination on vascular function. This study published in the...
